2007
DOI: 10.1016/j.ijantimicag.2006.12.016
|View full text |Cite
|
Sign up to set email alerts
|

Molecular basis of resistance to macrolides and lincosamides among staphylococci and streptococci from various animal sources collected in the resistance monitoring program BfT-GermVet

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
39
0
3

Year Published

2008
2008
2020
2020

Publication Types

Select...
7
3

Relationship

2
8

Authors

Journals

citations
Cited by 67 publications
(46 citation statements)
references
References 38 publications
1
39
0
3
Order By: Relevance
“…Previously established MIC breakpoints were used (13,14,18,27). The presence of the following resistance genes was determined by PCR: tetracycline resistance genes (30), and tet(W) (31); macrolide-lincosamide-streptogramin B (MLS B ) resistance genes erm(A), erm(B), (32), erm(C) (33), mef(A) and/or mef(E) (32), mph(C) (34), msr(A) and/or msr(B) (35), and msr(D) (36); phenicol resistance genes fexA and cfr (37) (38). Finally, the chromosomal mutations within the quinolone resistance-determining region (QRDR) of the gyrA and parC genes were determined in a subset of fluoroquinolone-resistant S. suis isolates (n ϭ 55), as described previously (19).…”
mentioning
confidence: 99%
“…Previously established MIC breakpoints were used (13,14,18,27). The presence of the following resistance genes was determined by PCR: tetracycline resistance genes (30), and tet(W) (31); macrolide-lincosamide-streptogramin B (MLS B ) resistance genes erm(A), erm(B), (32), erm(C) (33), mef(A) and/or mef(E) (32), mph(C) (34), msr(A) and/or msr(B) (35), and msr(D) (36); phenicol resistance genes fexA and cfr (37) (38). Finally, the chromosomal mutations within the quinolone resistance-determining region (QRDR) of the gyrA and parC genes were determined in a subset of fluoroquinolone-resistant S. suis isolates (n ϭ 55), as described previously (19).…”
mentioning
confidence: 99%
“…Resistance to lincosamides only (L phenotype) is exclusively based on the inactivation of lincosamides by nucleotidylation via Onucleotidyltransferases (6). Since the first report of a lincosamide nucleotidyltransferase gene, lnu(A) (formerly linA) (7), a number of lnu genes have been described in different bacteria from animal, human, and environmental sources, including lnu(B) (8), lnu(C) (9), lnu(D) (10), and lnu(F) (11). Most of these lnu genes confer resistance to lincomycin and pirlimycin, but their MICs for clindamycin are often below the breakpoints for resistance (2,9,10).…”
mentioning
confidence: 99%
“…Cli belongs to the family of Lincosamides, and according to Moellering (1991) resistance to such antimicrobial is common in enterococci, which may be considered a case of intrinsic resistance, with interspecies associations. For Lüthje and Schwarz (2007), bacterial resistance to lincosamide is related to efflux mechanisms and mutations. The susceptibility of enterococcal isolates to clindamycin was reported by Schmitz et al (1999) -only 4.4 of all E. faecalis strains from 20 European university hospitals were clindamycin-susceptible.…”
Section: Discussionmentioning
confidence: 99%